Transition of continuous subcutaneous insulin infusion systems in a very short time frame as a consequence of a public tender process

Pickup, 2009, NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidance, Diabet Med, 26, 1, 10.1111/j.1464-5491.2008.02617.x Pickup, 2008, Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, Diabet Med, 25, 765, 10.1111/j.1464-5491.2008.02486.x Monami, 2010, Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis, Acta Diabetol, 47, 77, 10.1007/s00592-009-0132-5 Yeh, 2012, Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis, Ann Intern Med, 157, 336, 10.7326/0003-4819-157-5-201209040-00508 Colquitt, 2004, Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes, Health Technol Assess, 8, iii, 10.3310/hta8430 Gimenez, 2007, Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service, Diabet Med, 24, 1419, 10.1111/j.1464-5491.2007.02287.x Grunberger, 2014, Consensus statement by the american association of clinical endocrinologists/american college of endocrinology insulin pump management task force, Endocr Pract, 20, 463, 10.4158/EP14145.PS White, 2014, The U.K. service level audit of insulin pump therapy in adults, Diabet Med, 31, 412, 10.1111/dme.12325 Renard, 2010, Insulin pump use in Europe, Diabetes Technol Ther, 12, S29, 10.1089/dia.2009.0189 Ziegler, 2013, ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems, Diabetes Technol Ther, 15, 738, 10.1089/dia.2013.0090